Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Enterprise Value: 9.948B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 9.948B |
| November 21, 2024 | 9.848B |
| November 20, 2024 | 9.794B |
| November 19, 2024 | 9.508B |
| November 18, 2024 | 9.550B |
| November 15, 2024 | 9.612B |
| November 14, 2024 | 9.794B |
| November 13, 2024 | 9.914B |
| November 12, 2024 | 10.05B |
| November 11, 2024 | 10.23B |
| November 08, 2024 | 10.17B |
| November 07, 2024 | 10.25B |
| November 06, 2024 | 10.19B |
| November 05, 2024 | 10.21B |
| November 04, 2024 | 10.14B |
| November 01, 2024 | 10.01B |
| October 31, 2024 | 9.796B |
| October 30, 2024 | 9.828B |
| October 29, 2024 | 9.736B |
| October 28, 2024 | 9.730B |
| October 25, 2024 | 9.674B |
| October 24, 2024 | 9.685B |
| October 23, 2024 | 9.801B |
| October 22, 2024 | 9.821B |
| October 21, 2024 | 9.801B |
| Date | Value |
|---|---|
| October 18, 2024 | 9.997B |
| October 17, 2024 | 9.928B |
| October 16, 2024 | 10.04B |
| October 15, 2024 | 10.19B |
| October 14, 2024 | 10.24B |
| October 11, 2024 | 10.20B |
| October 10, 2024 | 10.06B |
| October 09, 2024 | 10.32B |
| October 08, 2024 | 10.12B |
| October 07, 2024 | 10.07B |
| October 04, 2024 | 10.12B |
| October 03, 2024 | 10.12B |
| October 02, 2024 | 10.30B |
| October 01, 2024 | 10.42B |
| September 30, 2024 | 10.57B |
| September 27, 2024 | 10.57B |
| September 26, 2024 | 10.52B |
| September 25, 2024 | 10.31B |
| September 24, 2024 | 10.48B |
| September 23, 2024 | 10.39B |
| September 20, 2024 | 10.49B |
| September 19, 2024 | 10.64B |
| September 18, 2024 | 10.66B |
| September 17, 2024 | 10.66B |
| September 16, 2024 | 10.86B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.416B
Minimum
Dec 26 2019
14.04B
Maximum
Sep 02 2021
11.25B
Average
11.03B
Median
Jun 03 2020
Enterprise Value Benchmarks
| LENZ Therapeutics Inc | 759.18M |
| Oruka Therapeutics Inc | 318.28M |
| Boston Scientific Corp | 141.27B |
| Merus NV | 2.482B |
| uniQure NV | -102.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 98.06M |
| Revenue (Quarterly) | 501.87M |
| Total Expenses (Quarterly) | 381.02M |
| EPS Diluted (Quarterly) | 0.44 |
| Gross Profit Margin (Quarterly) | 61.43% |
| Profit Margin (Quarterly) | 19.54% |
| Earnings Yield | 0.95% |
| Operating Earnings Yield | 1.92% |
| Normalized Earnings Yield | 1.746 |